 Agenus Inc. NASDAQ:AGEN Q3 2022 Results Conference Call November 8, 2022 8:30 AM ET Company Participants Nico Frelick - Investor Relations Dr. Garo Armen - Chairman and Chief Executive Officer Christine Klaskin - Vice President of Finance Dr. Steven ODay - Chief Medical Officer Dhan Chand - Scientific Director, Head of Drug Discovery Conference Call Participants David Dye - SNBC Matt Phipps - William Blair Mayank Mamtani - B. Riley Securities Kelly Shi - Jefferies Operator Thanks for holding, and welcome everyone to the Agenus Third Quarter 2022 Financial Results Call. 